In hematopoietic malignancies, B-cell lymphomas with up-regulated AID have been shown to carry adverse mutations in genes, such as MYC, PIM1, and PAX5, as well as chromosomal abnormalities, including MYC/IGH rearrangements12,21–23. This evidence concerns the gene PAX5 and B-cell non-Hodgkin lymphoma.